We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Diconex

Diconex SA designs, develops, produces and markets clinical chemistry analyzers. Its products are used mainly by hosp... read more Featured Products: More products

Download Mobile App





Diconex S.A. Exhibits InCCA Intelligent Clinical Chemistry Analyzer at MEDICA 2019

By LabMedica International staff writers
Posted on 24 Nov 2019
Print article
Image: InCCA Intelligent Clinical Chemistry Analyzer (Photo courtesy of Diconex S.A.)
Image: InCCA Intelligent Clinical Chemistry Analyzer (Photo courtesy of Diconex S.A.)
Diconex S.A. (Buenos Aires, Argentina) exhibited its InCCA intelligent clinical chemistry analyzer the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. The MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care. The combination of product shows with international congresses, forums, as well as expert workshops, and the exchange of professional views make MEDICA a meeting point for international professionals from various fields in the medical sector.

Diconex designs, develops, produces and markets clinical chemistry analyzers, used mainly by hospitals, clinics, veterinary clinics and laboratories, scientific research centers, human laboratories, wine and food laboratories. At the 2019 edition of MEDICA, Diconex exhibited the InCCA intelligent clinical chemistry autoanalyzer for medium-volume laboratories. The open and random access system offers an automatic cuvette washer, easy-to-use software interface, and the lowest water consumption. It has an average throughput of 300 tests/hour (500 tests/hour with ISE), optimizes daily work performance, delivers high quality results, and provides safety and confidence to the user. Other features include reagents cooling, auto re-run with auto-dilution, interferences management, reagent inventory check and LIS interface.

Related Links:
Diconex S.A.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: ‘Virtual biopsy’ allows clinicians to analyze skin noninvasively (Photo courtesy of Stanford Medicine)

Virtual Skin Biopsy Determines Presence of Cancerous Cells

When dermatologists spot an unusual mark on a patient's skin, they face a choice: monitor it for some time or remove it for biopsy. Similarly, when removing breast tumors, surgeons must send excised tissues... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.